Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
All articles — 31199 total
VRTX reported Q3 earnings on November 2 and promptly fell 5%, a drop that left the stock at $530.76 despite a week-over-week gain of roughly 1.9%, and triggered a wave of analyst target increases that now sit well…
MMM closed at $177.05 on Tuesday, up 3.2% over the past week, against a median decline of roughly 0.3% for its closest correlated peers. The standout this week is not short interest, which remains negligible, but…
Thomson Reuters posted its sharpest single-day drop in recent memory on November 3, falling 9% to C$155.07 after reporting third-quarter results, leaving the stock down 5.2% on the week and erasing a substantial…
Tenet Healthcare has reversed the defensiveness flagged in last week's preview: the stock gained 1.8% on the week to $266.69, options hedging has unwound sharply, and analysts have responded to the earnings print with…
SAH is caught between a cluster of analyst target cuts, rising short interest, and a 10% owner buying aggressively into the dip, all at once. The stock closed at $60.68 on November 3, down nearly 5% on the day and…
Roper Technologies is trading at $473.58 after a 9% weekly gain, but the rally is attracting a building short position and a JP Morgan upgrade, leaving the stock caught between renewed institutional confidence and…
Manulife Financial Corporation goes into its Q3 earnings release today, November 4, with one genuinely unusual signal in the data: the cost to borrow its shares has more than doubled over the past week, even as short…
The Estée Lauder Companies Inc. fell 2.7% over the past week to $105.39, underperforming the median of its closest peers by roughly 2.4 percentage points, even as the most concentrated wave of analyst target upgrades…
Johnson & Johnson has pulled back from last week's cycle high, but the fundamental setup has not materially changed: short interest remains near a one-year low, the Street is broadly constructive, and the spinoff…
ExxonMobil has slipped back from its post-earnings high, closing Tuesday at $177.46 after a 1.4% weekly decline, yet the analyst community spent the same period racing to lift targets above where the stock is currently…
Exelon enters November with an interesting split between a strong one-month price recovery and a quietly rebuilding short position, two signals that rarely point in the same direction for a regulated utility. The stock…
Enpro Inc. delivered its most interesting session in months on November 3, closing up 6% to $285.27 on the back of quarterly results, and the analyst reaction since has sharpened the bull case considerably. The…
OVV slipped 6.6% on the week to $66.43, slightly worse than the median peer decline of around 5.8%, with DVN down 7.0% and CHRD off 6.2% at the deeper end, while COP and OXY held closer to 2% to 3% losses. The…
Columbus McKinnon delivered its sharpest weekly gain in recent memory, jumping 22% to $18.15 after a quarterly earnings release that appears to have caught bears flat-footed. The most immediate catalyst is an analyst…
CLX has gained 7.4% over the past week to $93.80, outpacing a peer median of 3.8%, yet short sellers have not retreated far enough to suggest the bear case is closing. Short interest in Clorox is now 8.74% of free…
BioMarin Pharmaceutical finds itself in an uncomfortable position this week: short sellers have been adding steadily even as a broad analyst consensus insists the stock is worth far more than its current price. The…
The most striking open-market buying in recent insider filings came from Kenneth Bryan Dart, the main shareholder of Swedish live-casino group EVO. Filings reported on 26 August showed Dart purchased over 10 million…
Hertz remains the most expensive short in the US market. Its cost to borrow hit 164% annualised on Wednesday. Short interest stands at 73.2% of free float. Zero shares are available to borrow. That combination makes…
Kraft Heinz heads into its November 12 earnings release with a short book that has started to unwind, even as options traders grow more cautious and the analyst community continues to trim its targets. Short interest…
The Chemours Company has moved sharply after its Q3 results, with the stock down nearly 2% on the week to $13.09 and options traders reversing from an unusually bullish stance into their most defensive posture in…
